HCA logo HCA Healthcare +
HCA Healthcare
+

HCA Healthcare (HCA) Business News

Track HCA Healthcare in real time with a live news feed covering HCA Healthcare stock news, official press releases, company announcements, and an archive of historical HCA Healthcare news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
9:55 AM | Tuesday | Jul 21, 2026 GlobeNewsWire

NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

NEW News Thumbnail
8:00 PM | Monday | Jul 20, 2026 GlobeNewsWire

HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

News Thumbnail
6:15 PM | Monday | Jul 20, 2026 Business Wire

NYSE: HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

News Thumbnail
3:14 PM | Sunday | Jul 19, 2026 Business Wire

HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm

News Thumbnail
7:52 PM | Thursday | Jul 16, 2026 PRNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

News Thumbnail
7:35 AM | Tuesday | Jul 14, 2026 Business Wire

HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call

News Thumbnail
7:30 AM | Tuesday | Jul 14, 2026 Business Wire

HCA Healthcare Previews Second Quarter 2026 Results

News Thumbnail
8:30 AM | Monday | Jun 29, 2026 Business Wire

HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children

News Thumbnail
9:00 AM | Tuesday | Jun 9, 2026 Business Wire

Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting

News Thumbnail
8:00 AM | Monday | Jun 8, 2026 Business Wire

Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting

News Thumbnail

NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

GlobeNewsWire

9:55 AM | Tuesday | Jul 21, 2026

news photo
Loading...

RADNOR, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc.
securities and experienced significant financial losses.

Read full article redirect
9:55 AM | Tuesday | Jul 21, 2026

NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

GlobeNewsWire

RADNOR, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc.
securities and experienced significant financial losses.

Read full article arrow
NEW News Thumbnail
8:00 PM | Monday | Jul 20, 2026

HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

GlobeNewsWire

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

Read full article arrow
News Thumbnail
6:15 PM | Monday | Jul 20, 2026

NYSE: HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

Business Wire

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc.
securities and experienced significant financial losses.HCA Announces Disappointing Financial ResultsOn July 14, 2026, HCA issued a press release reporting its preliminary financial an.

Read full article arrow
News Thumbnail
3:14 PM | Sunday | Jul 19, 2026

HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm

Business Wire

LOS ANGELES--(BUSINESS WIRE)---- $HCA--HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm.

Read full article arrow
News Thumbnail
7:52 PM | Thursday | Jul 16, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

PRNewsWire

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Read full article arrow
News Thumbnail
7:35 AM | Tuesday | Jul 14, 2026

HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call

Business Wire

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2026 Earnings Call When: Friday, July 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.
com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be.

Read full article arrow
News Thumbnail
7:30 AM | Tuesday | Jul 14, 2026

HCA Healthcare Previews Second Quarter 2026 Results

Business Wire

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures. HCA anticipates revenues in the second quarter of 2026 to approximate $20.
230 billion, compared to $18.605 billion in the second quarter of 2025. Net income attributable to HCA Healthcare.

Read full article arrow
News Thumbnail
8:30 AM | Monday | Jun 29, 2026

HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children

Business Wire

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. Sickle cell disease and beta thalassemia are inherited blood disorders that can cause serious, lifelong complications b.

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Jun 9, 2026

Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting

Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Mission Bio, the leader in single-cell multiomics solutions, today announced a collaboration with the Human Cell Atlas (HCA), a global consortium working to create comprehensive reference maps of all human cells to advance the understanding, diagnosis, and treatment of disease. The announcement comes ahead of the upcoming Human Cell Atlas General Meeting 2026, taking place June 16–18 in Boston, where Mission Bio will participate alongside leading researchers and.

Read full article arrow
News Thumbnail
8:00 AM | Monday | Jun 8, 2026

Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting

Business Wire

WALTHAM, Mass.--(BUSINESS WIRE)-- #HCA--Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping dataset in neurodegenerative brain tissue using MERFISH 2.0™ chemistry on the MERSCOPE Ultra Platform at the Human Cell Atlas (HCA) General Meeting, June 16-18, in Boston. The company will also launch Volumetric Tissue Mapping services and a new Cell Atlasing Hub, a central resource for the cell atlasing communi.

Read full article arrow
News Thumbnail